Revenue Growth
Net sales of $115.1 million, up 1% year-over-year (prior year quarter $114.0 million); increase primarily driven by pricing from tariff surcharges offsetting lower unit volume.
Operating Profitability Turnaround
GAAP operating income of $8.2 million, representing 7.1% operating margin, versus an operating loss of $5.1 million in the prior year quarter (prior year included a $14.1 million impairment).
Strong Cash and Liquidity Position
Cash balance of $57.3 million, working capital of $142.2 million, no bank debt; operating cash flow of $22.1 million for the quarter, driven in part by a $14.5 million reduction in inventory.
Inventory Normalization and Management
Inventory reduced sequentially (management noted a ~15% sequential decline in inventory), normalizing after elevated build ahead of tariff changes; company expects modest inventory growth next quarter to stock new product collections.
Product Mix and Margin Improvement
New product sales comprise roughly 40%–45% of company-level sales, contributing to favorable mix and higher margins; management cites differentiated innovation and product lifecycle management as key drivers of margin improvement.
Resilient Backlog and Strategic Accounts
Sales order backlog of $79.5 million, up ~1.5% year-over-year; strategic accounts, new product introductions and the health & wellness category continued to perform well and provided confidence in underlying growth drivers.